The “vigilance” aspect of the pharmacovigilance process can be very challenging. Always being on guard and knowing all of the places to look can be difficult. With so much information and so little time in a day, it can even seem like a nearly impossible task to maintain awareness of all adverse events (AEs).
This sample report demonstrates Nerac’s approach to providing basic search support including the raw content (title, abstract, and bibliographic information) to a larger, more thorough analysis for any periodic delivery needed. Access the sample report here.
The article is free!
Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
- 50By Joanne Ferrell and John Leavitt, Ph.D. Originally published October, 2013 Pharmacovigilance: What is it and why is it important? The requirements regarding post-market safety monitoring are more stringent now than ever. Numerous incidents involving marketed pharmaceuticals and over-the-counter (OTC) medicines in recent years have brought the issues of safety monitoring and risk management to…